Mary joined HealthTree in 2022. She is now the AML & MDS Community and Education Manager. She is passionate about giving power to patients through knowledge and health education. If she can help one patient feel more confident participating in discussions with their healthcare team and making treatment decisions, she will feel like she has succeeded. When she isn't advocating for patients, she loves being an aunt, attending concerts, and experimenting with new recipes in the kitchen.

Dr. Lai is an Associate Professor and Physician Leader of the Leukemia Clinical Research Unit at University of Pennsylvania’s Perelman Center for Advanced Medicine. Board-certified in hematology, oncology and internal medicine, she specializes in detecting, monitoring, and treating acute leukemias and myeloid malignancies in adults. Dr. Lai's research focuses on novel therapeutics, designing and conducting clinical trials, and health outcomes for leukemia and myeloid malignancy patients.

Dr. Mannis is Assistant Professor of Medicine in the Division of Hematology at Stanford University School of Medicine, and Medical Director of Stanford’s Inpatient Leukemia Service. He specializes in the treatment of acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), and other hematologic malignancies. As a clinical scientist, Dr. Mannis divides his time between caring for patients, teaching trainees, and researching novel therapies for AML and MDS.